ANNEX II, Regulation (EU) 2026/318

In forcesince 12 Feb 2026

Chapters 13 and 14 of Annex II to Implementing Regulation (EU) 2021/403 are replaced by the following:

COUNTRY | Animal health/official certificate to the EU

I.

1 | Consignor/Exporter | | I.2 | Certificate reference | I.2a | IMSOC reference

Name | | |

Address | | I.3 | Central Competent Authority | | QR CODE

Country | ISO country code | I.4 | Local Competent Authority | |

I.

5 | Consignee/Importer | | I.6 | Operator responsible for the consignment |

Name | | | Name |

Address | | | Address |

Country | ISO country code | | Country | ISO country code

I.

7 | Country of origin | ISO country code | I.9 | Country of destination | ISO country code

I.

8 | Region of origin | Code | I.10 | Region of destination | Code

I.

11 | Place of dispatch | | I.12 | Place of destination |

Name | Registration/Approval No | | Name | Registration/Approval No

Address | | | Address |

Country | ISO country code | | Country | ISO country code

I.

13 | Place of loading | I.14 | Date and time of departure

I.

15 | Means of transport | | I.16 | Entry Border Control Post

☐ Aircraft | ☐ Vessel | I.17 | Accompanying documents

☐ Railway | ☐ Road vehicle | | Type | Code

Identification | | Country | ISO country code

Commercial document reference |

I.

18 | | | |

I.

19 | Container number/Seal number

Container No | Seal No |

I.

20 | Certified as or for

☐ Further keeping | ☐ Registered equine animal | ☐Registered horse |

I.

21 | ☐ For transit | I.22 | ☐ For internal market

Third country | ISO country code | I.23 |

I.

24 | | I.25 | Total quantity | I.26 |

I.

27 | Description of consignment

CN code | Species | Subspecies/Category | Sex | Identification system | Identification number | Age |

COUNTRY | Certificate model EQUI-X

II.

Health information

II.

a | Certificate reference | II.b | IMSOC reference

II.

Animal health attestation

I, the undersigned official veterinarian, hereby certify that:

II.

1. The equine animal described in Part I:

II.

1.1. is not intended for slaughter for human consumption and not intended for slaughter in the framework of the eradication of infectious or contagious diseases transmissible to equine animals, and

(1)

either [is a registered equine animal, as defined in Article 2, point (12), of Commission Delegated Regulation (EU) 2020/692;]

(1)

or [is a registered horse as defined in Article 2, point (12), of Delegated Regulation (EU) 2020/692;]

(1)

or [is an equine animal other than a registered equine animal or a registered horse;]

II.

1.2. has not shown signs or symptoms of diseases listed for equine animals in Commission Implementing Regulation (EU) 2018/1882 during the clinical examination carried out on …/…/… (dd/mm/yyyy) (2), this date being within the last 24 hours or, in the case of a registered equine animal, within the last 48 hours or on the last working day prior to the date of dispatch of the animal to the Union from the registered establishment;

II.

1.3. meets the requirements attested in points II.2 to II.5, and where applicable in point II.6, of this animal health/official certificate;

II.

1.4. is accompanied by a written declaration, signed by the operator responsible for the animal, which is attached to this animal health/official certificate.

II.

2. Attestation on third country or territory, or zone thereof and establishment of dispatch

II.

2.1. The equine animal described in Part I is dispatched from … (insert name of third country or territory, or zone thereof), a third country or territory, or zone thereof, which on the date of issuing this animal health/official certificate has the code …-… (3) and is assigned to Sanitary Group … (3).

II.

2.2. The equine animal described in Part I comes from a third country or territory, or zone thereof in which there has been no clinical, serological (in unvaccinated equine animals) or epidemiological evidence of African horse sickness during the last 24 months prior to the date of dispatch of the animal to the Union, and there has been no vaccination against African horse sickness during the last 12 months prior to the date of dispatch of the animal to the Union.

II.

2.3. The equine animal described in Part I comes from an establishment situated in a third country or territory, or zone thereof in which

(1)

either [infection with Burkholderia mallei (glanders) has not been reported during the last 36 months prior to the date of dispatch of the animal to the Union.]

(1)

or [a surveillance programme for infection with Burkholderia mallei (glanders) recognised by the Union (2) has been carried out during the last 36 months prior to the date of dispatch of the animal to the Union, and

(1)

either [infection with Burkholderia mallei (glanders) has not been reported in the establishment of dispatch during the last 36 months prior to the date of dispatch of the animal to the Union.]]

(1)

or [infection with Burkholderia mallei (glanders) has been reported in the establishment during the last 36 months prior to the date of dispatch of the animal to the Union and following the date of last outbreak, the establishment has remained under movement restrictions

(1)

either [until the date on which the remaining equine animals in the establishment have been subjected to a complement fixation test for infection with Burkholderia mallei (glanders) (4), carried out, with negative results at a serum dilution of 1 in 5, on samples taken at least 6 months after the date on which the infected animals have been killed and destroyed.]]]

(1)

or [for at least 30 days after the date on which the last animal of listed species on the establishment was killed and destroyed, and the establishment was cleaned and disinfected.]]]

II.

2.4. The equine animal described in Part I comes from an establishment situated in a third country or territory, or zone thereof in which

(1)

either [surra has not been reported during the last 24 month prior to the date of dispatch of the animal to the Union.]

(1)

or [a surveillance programme for surra recognised by the Union (2) has been carried out during the last 24 months prior to the date of dispatch of the animal to the Union, and

(1)

either [surra has not been reported in the establishment during the last 24 months prior to the date of dispatch of the animal to the Union.]]

(1)

or [surra has been reported in the establishment during the last 24 months prior to the date of dispatch of the animal to the Union, and following the last outbreak, the establishment has remained under movement restrictions

(1)

either [until the date on which the remaining animals in the establishment have been subjected to an enzyme-linked immunosorbent assay (ELISA) for trypanosomosis or card agglutination test for trypanosomosis (CATT) at a serum dilution of 1 in 4 (4) carried out, with negative results, on samples taken at least 6 months after the date on which the last infected animal has been removed from the establishment.]]]

(1)

or [for at least 30 days after the date on which the last animal of listed species on the establishment was either killed and destroyed or slaughtered, and the establishment was cleaned and disinfected.]]]

II.

2.5. The equine animal described in Part I comes from an establishment situated in a third country or territory, or zone thereof in which

(1)

either [dourine has not been reported during the last 24 months prior to the date of dispatch of the animal to the Union.]

(1)

or [a surveillance programme for dourine recognised by the Union (2) has been carried out during the last 24 months prior to the date of dispatch of the animal to the Union, and

(1)

either [dourine has not been reported in the establishment during the last 24 months prior to the date of dispatch of the animal to the Union.]]

(1)

or [dourine has been reported in the establishment during the last 24 months prior to the date of dispatch of the animal to the Union, and following the last outbreak, the establishment has remained under movement restrictions

(1)

either [until the date on which the remaining equine animals in the establishment, except castrated male equine animals, have been subjected to a complement fixation test for dourine, carried out with negative results at a serum dilution of 1 in 5 (4) on samples taken at least 6 months after the date on which the infected animals have been killed and destroyed or slaughtered, or the date on which the infected entire male equine animals have been castrated.]]]

(1)

or [for at least 30 days after the date on which the last animal of listed species on the establishment was either killed and destroyed or slaughtered, and the establishment was cleaned and disinfected.]]]

II.

2.6. The equine animal described in Part I comes from an establishment in which

(1)

either [equine infectious anaemia has not been reported during the last 12 months prior to the date of dispatch of the animal to the Union.]

(1)

or [equine infectious anaemia has been reported during the last 12 months prior to the date of dispatch of the animal to the Union and following the last outbreak, the establishment has remained under movement restrictions

(1)

either [until the date on which the remaining equine animals in the establishment have been subjected to an agar gel immuno-diffusion test (AGID or Coggins test) or ELISA (4) for equine infectious anaemia carried out, with negative results, on samples taken on two occasions with a minimum interval of 90 days following the date on which the infected animals have been killed and destroyed, or slaughtered, and the establishment was cleaned and disinfected.]]

(1)

or [for at least 30 days after the date on which the last animal of listed species on the establishment was either killed and destroyed or slaughtered, and the establishment was cleaned and disinfected.]]

II.

2.7. The equine animal described in Part I comes from an establishment in which:

II.

2.7.1. infection with rabies virus in kept terrestrial animals has not been reported during the last 30 days prior to the date of dispatch of the animal to the Union;

II.

2.7.2. anthrax in ungulates has not been reported during the last 15 days prior to the date of dispatch of the animal to the Union.

II.

2.8. To the best of my knowledge and as declared by the operator, the equine animal described in Part I has not been in contact with kept animals of listed species which did not comply with the requirements referred to in points II.2.2 to II.2.7.1 during the last 30 days prior to the date of dispatch of the animal to the Union, and with the requirement referred to in point II.2.7.2 during the last 15 days prior to the date of dispatch of the animal to the Union.

II.

3. Attestation of residence and isolation prior to dispatch to the Union

(1)

either [II.3.1. During the last 40 days prior to the date of its dispatch to the Union, or since birth if it is less than 40 days of age, the equine animal described in Part I has been continuously resident in the third country or territory, or zone thereof of dispatch or entered the third country or territory, or zone thereof of dispatch from a Member State of the European Union or Norway.]

(1)

or [II.3.1. During the last 40 days prior to the date of its dispatch to the Union, or since birth if it is less than 40 days of age, the registered horse described in Part I

(1)

either [has been continuously resident in the third country or territory, or zone thereof of dispatch.]

(1)

or [entered the third country or territory, or zone thereof of dispatch on one or more occasions from:

(1)

either [a Member State of the European Union or Norway;]]]

(1)

and/or [a third country or territory, or zone thereof authorised for the entry into the Union of registered horses, and from which it was introduced into the third country or territory, or zone thereof of dispatch under conditions at least as strict as those required in accordance with Union legislation for the entry of registered horses from that third country or territory, or zone thereof directly to the Union, and which is:

(1)

either [assigned to the same Sanitary Group ______ (3) as the third country or territory, or zone thereof of dispatch;]]]]

(1)

and/or [assigned to Sanitary Group A, B or C;]]]]

(1)

and/or [the United Arab Emirates, Bahrain, China (5) (6), South Korea, Hong Kong, Japan, Macao or Singapore.]]]]

(1)

either [II.3.2. The equine animal described in Part I is dispatched from a third country or territory, or zone thereof assigned to Sanitary Group A, B, C, D or G, and

(1)

either [during the last 30 days prior to the date of its dispatch to the Union, or since birth if it is less than 30 days of age or since entry from a Member State of the Union or Norway,

(1)

either [it has been kept apart from other equine animals, except in case of a foal at foot of his mother, in an establishment situated in a third country or territory, or zone thereof assigned to Sanitary Group A.]]]

(1)

or [it has been kept in pre-export isolation from other equine animals, except in case of a foal at foot of his mother, in an establishment situated in a third country or territory, or zone thereof assigned to Sanitary Group B, C, D or G.]]]

(1)

or [it is a registered horse which has been kept in establishments under official veterinary supervision during the last 30 days prior to the date of its dispatch to the Union, or since birth if it is less than 30 days of age, or since entry in accordance with point II.3.1 from a Member State of the European Union, Norway or a third country or territory, or zone thereof which is assigned to Sanitary Group A, B, C, D, E or G.]]

(1)

(7) or [II.3.2. The equine animal described in Part I is dispatched from a third country or territory, or zone thereof assigned to Sanitary Group E, and

(1)

either [during the last 40 days prior to the date of its dispatch to the Union, or since birth if it is less than 40 days of age, or since the date of entry in accordance with point II.3.1 from a Member State of the European Union, Norway or a third country or territory, or zone thereof which is assigned to Sanitary Group A, B, C, D, E or G, it has been kept

(1)

either [in isolation in a vector-protected establishment.]]]

(1)

or [in an establishment under official veterinary supervision, and the country or territory, or zone thereof of dispatch is recognised by the World Organisation for Animal Health (WOAH) as officially free of African horse sickness.]]]

(1)

or [is a registered horse which has been kept during the last 30 days prior to the date of its dispatch, or since birth if it is less than 30 days of age, or since the date of entry in accordance with point II.3.1 from a Member State of the European Union, Norway or a third country or territory, or zone thereof which is assigned to Sanitary Group A, B, C, D, E or G, in the establishments under official veterinary supervision, and the third country or territory, or zone thereof of dispatch to the Union is recognised by the WOAH as officially free of African horse sickness.]]

(1)

(7) or [II.3.2. The registered horse described in Part I is dispatched from a third country or territory, or zone thereof assigned to Sanitary Group F, and

(1)

either [during the last 40 days prior to the date of dispatch it has been kept in isolation in a vector-protected establishment.]]

(1)

or [during the last 14 days prior to the date of dispatch to the Union it has been kept in isolation in a vector-protected establishment and constant monitoring of the vector protection has proven absence of insect vectors inside the vector-protected establishment.]]

II.

4. Attestation of vaccination and health tests

(1)

either [II.4.1. The equine animal described in Part I was not vaccinated against African horse sickness in the third country or territory, or zone thereof of dispatch and there is no information suggesting previous vaccination.]

(1)

or [II.4.1. The equine animal described in Part I was vaccinated against African horse sickness more than 12 months prior to the date of its dispatch to the Union.]

(1)

(7) or [II.4.1. The registered horse described in Part I was vaccinated against African horse sickness not more than 24 months and at least 40 days prior to the date of introduction into the vector-protected establishment situated in a third country or territory, or zone thereof assigned to Sanitary Group F, and this vaccination consisted of a complete primary course of vaccination against African horse sickness, or a revaccination within the period of validity of the previous vaccination, by administration according to manufacturer's instructions of a registered vaccine which is protective against the circulating serotypes of the African horse sickness virus, and the last vaccination was applied on …/…/… (dd/mm/yyyy).]

II.

4.2. The equine animal described in Part I has not been vaccinated against Venezuelan equine encephalomyelitis during the last 60 days prior to the date of its dispatch to the Union, and

(1)

either [it comes from an establishment situated in a third country or territory in which Venezuelan equine encephalomyelitis has not been reported during the last 24 months prior to the date of its dispatch to the Union.]

(1)

or [it comes from an establishment in which Venezuelan equine encephalomyelitis has not been reported during the last 6 months prior to the date of its dispatch to the Union and during the last 21 days prior to the date of dispatch of the animal described in Part I to the Union, all equine animals in the establishment have remained clinically healthy, and

(1)

either [the equine animal described in Part I has been kept protected from attacks by insect vectors in a vector-protected establishment, in which any equine animal that showed a rise in daily taken body temperature has been subjected with negative result to a virus isolation test for Venezuelan equine encephalomyelitis (4); and the equine animal described in Part I

(1)

either [was vaccinated against Venezuelan equine encephalomyelitis with a complete primary course and revaccinated according to manufacturer's recommendations not less than 60 days and not more than 12 months prior to the date of dispatch of the animal to the Union.]]]

(1)

or [was subjected to a haemagglutination inhibition test for Venezuelan equine encephalomyelitis (4), carried out, with negative result, on a sample taken not less than 14 days after the date of commencement of isolation in the vector-protected establishment.]]]

(1)

or [the body temperature of the equine animal described in Part I has been taken daily, either without a rise or the animal has been subjected to a virus isolation test for Venezuelan equine encephalomyelitis with negative result, and the equine animal described in Part I has been subjected to:

(a)

a haemagglutination inhibition test for Venezuelan equine encephalomyelitis (4), without an increase in antibody titre, carried out on paired samples taken on two occasions with an interval of 21 days, the second of which was taken during the last 10 days prior to the date of its dispatch to the Union, and

(b)

a reverse transcription-polymerase chain reaction (RT-PCR) for the detection of Venezuelan equine encephalomyelitis virus genome (4), with negative result, carried out on a sample taken within the last 48 hours prior to its dispatch to the Union, and

(c)

protection from vector attacks during the period after the date of sampling until loading for dispatch to the Union, by combined use of approved insect repellents and insecticides on the animal and disinsectization of the stable and the means in which it is transported.]]

(1)

(7) either [II.4.3. The equine animal described in Part I is dispatched to the Union from Iceland, which is certified as officially free from equine infectious anaemia, where it was continuously resident since birth, and did not come into contact with equine animals which have entered Iceland from other third countries or territories.]

(1)

or [II.4.3. The equine animal described in Part I was subjected with negative result to an agar gel immunodiffusion test (AGID or Coggins test) or to an ELISA for equine infectious anaemia (4) carried out on a blood sample taken on …/…/… (dd/mm/yyyy), this being within

(1)

either [the last 30 days prior to the date of its dispatch to the Union.]]

(1)

(7) or [the last 90 days prior to the date of its dispatch to the Union from a third country or territory, or zone thereof assigned to Sanitary Group A.]]

(1)

[II.4.4. The equine animal described in Part I is dispatched from a third country or territory, or zone thereof assigned to Sanitary Group B, D or E, or from China, or from a third country or territory in which infection with Burkholderia mallei (glanders) has been reported during the last 36 months prior to the date of its dispatch to the Union, and the equine animal was subjected to a complement fixation test for infection with Burkholderia mallei (glanders) (4) carried out with negative result at a serum dilution of 1 in 5 on a blood sample taken on …/…/… (dd/mm/yyyy), within the last 30 day prior to the date of its dispatch to the Union.]

(1)

[II.4.5. The equine animal described in Part I is an uncastrated male or female equine animal older than 270 days dispatched from a third country or territory, or zone thereof assigned to Sanitary Group B, D, E or F, or from China, or from a third country or territory in which dourine has been reported during the last 24 months prior to the date of its dispatch to the Union, and the equine animal was subjected to a complement fixation test for dourine (4) carried out with negative result at a serum dilution of 1 in 5 on a blood sample taken on …/…/… (dd/mm/yyyy), within the last 30 days prior to the date of its dispatch to the Union, and the equine animal described in Part I has not been used for breeding during 30 days prior to and after the date the sample was taken.]

(1)

[II.4.6. The equine animal described in Part I is dispatched to the Union from a third country or territory, or zone thereof assigned to Sanitary Group E, or from Bolivia, Brazil, Uruguay, or from a third country or territory in which surra was reported during the last 24 months prior to the date of its dispatch to the Union; and the equine animal was subjected to a card agglutination test for trypanosomosis (CATT) (4) carried out with negative result at a serum dilution of 1 in 4 on a blood sample taken on …/…/… (dd/mm/yyyy), within the last 30 days prior to the date of its dispatch to the Union.]

(1)

(7) [II.4.7. The equine animal described in Part I is dispatched to the Union from a third country or territory, or zone thereof which is assigned to Sanitary Group E, and

This article is long: the rest is at the official publication.